Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NSCLC × Radiotherapy × Clear all

Phase

Phase 2 3 Phase 1 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Prostatic Neoplasms 25 Lymphoma 12 Carcinoma, Non-Small-Cell Lung 12 Head and Neck Neoplasms 11 Recurrence 10 Rectal Neoplasms 10 Neoplasms 9 Lung Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Esophageal Squamous Cell Carcinoma 7 Central Nervous System Neoplasms 7 Uterine Cervical Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Esophageal Neoplasms 6 Carcinoma, Hepatocellular 6 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Follicular 5 Hyperthermia 5 Hodgkin Disease 5 Dendritic Cell Sarcoma, Interdigitating 5 Congenital Abnormalities 5 Carcinoma, Intraductal, Noninfiltrating 5 Burkitt Lymphoma 5 Sarcoma 4 Primary Myelofibrosis 4

Interventions

sugemalimab 1 spartalizumab 1 Vinorelbine 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869685 2024-02-23

RadImm02

Xinqiao Hospital of Chongqing

Phase NA Completed

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡